Market Cap 20.12M
Revenue (ttm) 10.91M
Net Income (ttm) -43.39M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -397.71%
Debt to Equity Ratio 0.00
Volume 204,700
Avg Vol 74,684
Day's Range N/A - N/A
Shares Out 12.50M
Stochastic %K 43%
Beta 3.86
Analysts Strong Sell
Price Target $14.50

Company Profile

Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small-molecule IRAK4 kinase inhibitor, which is in a Phase 1/2 open-label, single-arm expansion trial in patients with relapsed or refractory, or R/R, AML and high-risk myelodysplastic syndromes. The company's pipeline also includes Fimepinostat, an oral dual inhibitor of HDAC and...

Industry: Biotechnology
Sector: Healthcare
Phone: 617 503 6500
Address:
Building C, Suite 500 128 Spring Street, Lexington, United States
RedDrumification
RedDrumification Oct. 27 at 2:10 PM
$CRIS been invested with them a long time. thoughts on most likely outcome for Q1?
0 · Reply
jeremy50641
jeremy50641 Oct. 27 at 1:51 AM
$CRIS so by my calculations this would have to get up to $2.80 a share by Nov 4th in order to not get delisted. Just wondering if that is correct.
1 · Reply
MaiXin
MaiXin Oct. 25 at 11:09 AM
$CRIS ...delisting shortly before the start of the ASH. That would be another coincidence 😁. Then, a few days later, exciting new PCNSL data is released, and no one can officially trade the stock anymore. You'd think this was all prearranged 😂. Well, let's hope something happens in the next three weeks. Even if they're only traded OTC, I'll stay on board and won't let myself be confused. If I go down, I'll go down with a bang
0 · Reply
BallWasher69
BallWasher69 Oct. 24 at 8:45 PM
$CRIS new 8k out…we have until 11/14 to gain compliance not to be delisted….tic tock
0 · Reply
Topzero
Topzero Oct. 22 at 12:45 PM
$CRIS fky*** ‏ Owner company
0 · Reply
MaiXin
MaiXin Oct. 20 at 1:18 PM
$CRIS I would like to remind you that Curis Inc. received the grant of its patent on December 31, 2024 and thus enjoys legal protection until 2042. https://patents.google.com/patent/US12178821B2/en?oq=US12178821 I still don't understand why this hasn't generated any attention yet. All we can do is wait and keep our fingers crossed.
1 · Reply
MaiXin
MaiXin Oct. 17 at 7:48 AM
$CRIS New Poster !!! Emavusertib in Combination with Gemcitabine and Nab-paclitaxel in Metastatic or Unresectable Pancreatic Ductal Adenocarcinoma AACR 2025 Poster https://www.curis.com/wp-content/uploads/2025/10/Emavusertib-in-Pancreatic-Ductal-Adenocarcinoma-PDAC-AACR-2025.pdf
1 · Reply
6monthinvester
6monthinvester Oct. 16 at 2:22 PM
$CRIS can be. A high risk gem
0 · Reply
LodiDodiWeLikesToParty
LodiDodiWeLikesToParty Oct. 15 at 3:12 AM
$CRIS scam
0 · Reply
UCD_12dd
UCD_12dd Oct. 13 at 8:59 PM
$CRIS this thing is losing its pulse and on life support… What gives? 
0 · Reply
Latest News on CRIS
Curis, Inc. (CRIS) Q2 2025 Earnings Call Transcript

Aug 5, 2025, 11:25 AM EDT - 2 months ago

Curis, Inc. (CRIS) Q2 2025 Earnings Call Transcript


Curis Provides Second Quarter 2025 Business Update

Aug 5, 2025, 8:00 AM EDT - 2 months ago

Curis Provides Second Quarter 2025 Business Update


Curis, Inc. (CRIS) Q1 2025 Earnings Call Transcript

May 6, 2025, 2:40 PM EDT - 6 months ago

Curis, Inc. (CRIS) Q1 2025 Earnings Call Transcript


Curis Provides First Quarter 2025 Business Update

May 6, 2025, 8:00 AM EDT - 6 months ago

Curis Provides First Quarter 2025 Business Update


Curis to Present at Upcoming Healthcare Conference in April

Apr 2, 2025, 4:05 PM EDT - 7 months ago

Curis to Present at Upcoming Healthcare Conference in April


Curis, Inc. (CRIS) Q4 2024 Earnings Call Transcript

Mar 31, 2025, 9:59 AM EDT - 7 months ago

Curis, Inc. (CRIS) Q4 2024 Earnings Call Transcript


Curis Provides Fourth Quarter 2024 Business Update

Mar 31, 2025, 8:00 AM EDT - 7 months ago

Curis Provides Fourth Quarter 2024 Business Update


Curis Announces Additional Data from TakeAim Leukemia Study

Dec 10, 2024, 8:00 AM EST - 11 months ago

Curis Announces Additional Data from TakeAim Leukemia Study


Curis, Inc. (CRIS) Q3 2024 Earnings Call Transcript

Nov 14, 2024, 11:02 AM EST - 1 year ago

Curis, Inc. (CRIS) Q3 2024 Earnings Call Transcript


Curis Provides Third Quarter 2024 Business Update

Nov 14, 2024, 8:00 AM EST - 1 year ago

Curis Provides Third Quarter 2024 Business Update


Curis Announces the 3rd Annual Symposium on IRAK4 in Cancer

Sep 23, 2024, 8:30 AM EDT - 1 year ago

Curis Announces the 3rd Annual Symposium on IRAK4 in Cancer


Curis, Inc. (CRIS) Q2 2024 Earnings Call Transcript

Aug 1, 2024, 3:44 PM EDT - 1 year ago

Curis, Inc. (CRIS) Q2 2024 Earnings Call Transcript


Curis to Present at Upcoming Healthcare Conference in July

Jul 10, 2024, 7:30 AM EDT - 1 year ago

Curis to Present at Upcoming Healthcare Conference in July


Curis to Present Updated Data from the TakeAim Leukemia Study

May 10, 2024, 8:00 AM EDT - 1 year ago

Curis to Present Updated Data from the TakeAim Leukemia Study


Curis, Inc. (CRIS) Q1 2024 Earnings Call Transcript

May 7, 2024, 8:08 PM EDT - 1 year ago

Curis, Inc. (CRIS) Q1 2024 Earnings Call Transcript


Curis Provides First Quarter 2024 Business Update

May 7, 2024, 8:00 AM EDT - 1 year ago

Curis Provides First Quarter 2024 Business Update


Curis to Present at Upcoming Healthcare Conferences in April

Apr 4, 2024, 7:30 AM EDT - 1 year ago

Curis to Present at Upcoming Healthcare Conferences in April


Curis, Inc. (CRIS) Q4 2023 Earnings Call Transcript

Feb 8, 2024, 2:04 PM EST - 1 year ago

Curis, Inc. (CRIS) Q4 2023 Earnings Call Transcript


Curis Provides Fourth Quarter 2023 Business Update

Feb 8, 2024, 8:00 AM EST - 1 year ago

Curis Provides Fourth Quarter 2023 Business Update


Curis Announces Three Presentations at ASH

Dec 6, 2023, 8:00 AM EST - 2 years ago

Curis Announces Three Presentations at ASH


Curis's stock rises as analysts see ‘the next Pharmacyclics'

Nov 17, 2023, 9:04 AM EST - 2 years ago

Curis's stock rises as analysts see ‘the next Pharmacyclics'


Curis, Inc. (CRIS) Q3 2023 Earnings Call Transcript

Nov 2, 2023, 2:32 PM EDT - 2 years ago

Curis, Inc. (CRIS) Q3 2023 Earnings Call Transcript


Curis Provides Third Quarter 2023 Business Update

Nov 2, 2023, 8:00 AM EDT - 2 years ago

Curis Provides Third Quarter 2023 Business Update


Curis Announces Date for the 2nd Symposium on IRAK4 in Cancer

Sep 12, 2023, 8:00 AM EDT - 2 years ago

Curis Announces Date for the 2nd Symposium on IRAK4 in Cancer


Curis, Inc. (CRIS) Q2 2023 Earnings Call Transcript

Aug 3, 2023, 9:35 PM EDT - 2 years ago

Curis, Inc. (CRIS) Q2 2023 Earnings Call Transcript


Curis Provides Second Quarter 2023 Business Update

Aug 3, 2023, 4:01 PM EDT - 2 years ago

Curis Provides Second Quarter 2023 Business Update


Curis Announces $15.1 Million Registered Direct Offering

Jul 6, 2023, 8:00 AM EDT - 2 years ago

Curis Announces $15.1 Million Registered Direct Offering


Curis, Inc. (CRIS) Q1 2023 Earnings Call Transcript

May 4, 2023, 9:59 PM EDT - 2 years ago

Curis, Inc. (CRIS) Q1 2023 Earnings Call Transcript


RedDrumification
RedDrumification Oct. 27 at 2:10 PM
$CRIS been invested with them a long time. thoughts on most likely outcome for Q1?
0 · Reply
jeremy50641
jeremy50641 Oct. 27 at 1:51 AM
$CRIS so by my calculations this would have to get up to $2.80 a share by Nov 4th in order to not get delisted. Just wondering if that is correct.
1 · Reply
MaiXin
MaiXin Oct. 25 at 11:09 AM
$CRIS ...delisting shortly before the start of the ASH. That would be another coincidence 😁. Then, a few days later, exciting new PCNSL data is released, and no one can officially trade the stock anymore. You'd think this was all prearranged 😂. Well, let's hope something happens in the next three weeks. Even if they're only traded OTC, I'll stay on board and won't let myself be confused. If I go down, I'll go down with a bang
0 · Reply
BallWasher69
BallWasher69 Oct. 24 at 8:45 PM
$CRIS new 8k out…we have until 11/14 to gain compliance not to be delisted….tic tock
0 · Reply
Topzero
Topzero Oct. 22 at 12:45 PM
$CRIS fky*** ‏ Owner company
0 · Reply
MaiXin
MaiXin Oct. 20 at 1:18 PM
$CRIS I would like to remind you that Curis Inc. received the grant of its patent on December 31, 2024 and thus enjoys legal protection until 2042. https://patents.google.com/patent/US12178821B2/en?oq=US12178821 I still don't understand why this hasn't generated any attention yet. All we can do is wait and keep our fingers crossed.
1 · Reply
MaiXin
MaiXin Oct. 17 at 7:48 AM
$CRIS New Poster !!! Emavusertib in Combination with Gemcitabine and Nab-paclitaxel in Metastatic or Unresectable Pancreatic Ductal Adenocarcinoma AACR 2025 Poster https://www.curis.com/wp-content/uploads/2025/10/Emavusertib-in-Pancreatic-Ductal-Adenocarcinoma-PDAC-AACR-2025.pdf
1 · Reply
6monthinvester
6monthinvester Oct. 16 at 2:22 PM
$CRIS can be. A high risk gem
0 · Reply
LodiDodiWeLikesToParty
LodiDodiWeLikesToParty Oct. 15 at 3:12 AM
$CRIS scam
0 · Reply
UCD_12dd
UCD_12dd Oct. 13 at 8:59 PM
$CRIS this thing is losing its pulse and on life support… What gives? 
0 · Reply
Topzero
Topzero Oct. 13 at 4:02 PM
$CRIS everyone sale I think company close
0 · Reply
Yodalay
Yodalay Oct. 10 at 5:35 PM
$CRIS Why are they hiring new employees? Oct. 3: "grant of inducement stock options to purchase a total of 84,750 shares of Curis common stock to two new employees. https://investors.curis.com/2025-10-03-Curis-Reports-Inducement-Grants-Under-NASDAQ-Listing-Rule-5635-c-4 What have Hamdy and Zung done for this company? Hard to understand Dentzer's thinking....no sense
0 · Reply
LodiDodiWeLikesToParty
LodiDodiWeLikesToParty Oct. 8 at 9:41 PM
$CRIS I can't wait for the next group of excuses and postponement while our investment withers away to nothing. Four plus years of the same.
0 · Reply
Raxothus
Raxothus Oct. 7 at 7:54 PM
$CRIS - Research Notes Date/time checked: 2025-10-07 (ET) Identity & price: Curis, Inc. (NASDAQ: CRIS). Current trading ~ $1.60–1.65. Filings/news last 90d: • Q2 2025 update: net loss $8.6M, revenue $2.7M (royalties), cash at ~$10.1M, project runway into early 2026 with $6M raise • $7M registered direct + private placement closed July 2025: 1.54M shares + pre-funded warrants + common warrants structure Dilution risk: Significant, new shares + warrants issued; warrants exercisable; existing shareholders’ stake could see ~50–60% overhang if fully exercised Liquidity: Moderate for small biotech; daily volume thin, wide spreads. Balance sheet: Operating losses, R&D heavy; modest cash cushion post-raise; burn rate and need for further raises remain concern. Catalysts: Upcoming ASH/oncology conference data, clinical readouts for Emavusertib, partnering/licensing announcements. Sources: https://www.curis.com/ https://www.prnewswire.com/news-releases/curis-announces-7-0-million-registered-direct-and-concurrent-private-placement-302496802.html https://www.prnewswire.com/news-releases/curis-announces-7-0-million-registered-direct-and-concurrent-private-placement-302496802.html
0 · Reply
Raxothus
Raxothus Oct. 7 at 7:49 PM
Deep Value Daily – $CRIS Current $1.61 vs Alpha Spread → Worst Case $7.35, Base Case $15.07, Best Case $23.48 Undervalue %: WC 78.10%, Base 89.32%, Best 93.14% Country: United States Pros: Clinical-stage oncology pipeline (Emavusertib IRAK4, Fimepinostat, CA-170); recent FDA/EMA alignment for accelerated path in PCNSL; the base of model implies ~5–10× upside. Cons: Recently raised $7M via stock + warrant offering — heavy dilution risk; operating losses, burn, thin liquidity; clinical trial risk is binary for biotech. Entry Idea: Watch reclaim above $2.50 with volume; invalidate if it falls and holds < $1.20. Stay disciplined, keep hunting, keep surviving. #DeepValueDaily #IntrinsicValue #SmallCaps
0 · Reply
BallWasher69
BallWasher69 Oct. 7 at 10:22 AM
$CRIS we can dream that we will have our $SPRB moment sooner than later 🙏🏻
0 · Reply
Yodalay
Yodalay Oct. 5 at 5:51 PM
$CRIS If ever there was a time for good news.....it would be soon. BioTech catching a bid, M&A happening, valuations climbing...
1 · Reply
Yodalay
Yodalay Oct. 2 at 6:46 PM
$CRIS Whatever happened to Baby Gangster Twits? He had some good insights on CRIS back in the day....
0 · Reply
BallWasher69
BallWasher69 Oct. 1 at 4:58 PM
$CRIS happy October $CRIS longs ….still here waiting patiently ….
2 · Reply
UCD_12dd
UCD_12dd Sep. 23 at 7:59 PM
$CRIS groundhog Day: green after hours, red during hours. Same old, broken record. 
0 · Reply
JuanPiirto992
JuanPiirto992 Sep. 21 at 6:26 AM
$CRIS Biotech with catalyst upcoming. High short interest. Volatility expansion expected.
0 · Reply
LodiDodiWeLikesToParty
LodiDodiWeLikesToParty Sep. 20 at 12:52 AM
$CRIS they are not any closer to FDA approval than they were 4 years ago. The problem is that cash has almost run out and they are about to be delisted from the nasdaq.
0 · Reply